Nicholas Dracopoli, Ph.D. is Vice President and Head of Oncology Biomarkers at Janssen Research & Development, LLC. In this role, he is responsible for biomarker discovery, development and application for oncology products.
Prior to Janssen Research & Development, he was Vice President of Clinical Discovery Technologies at Bristol-Myers Squibb and also spent five years in the biotechnology industry at Sequana Therapeutics.
Nicholas obtained his bachelor’s degree and doctorate from the University of London and completed post-doctoral fellowships at the Memorial Sloan-Kettering Cancer Center in New York City and the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts. Subsequently, he served as an Assistant Director at the Whitehead/MIT Genome Center and as a Section Chief at the National Center for Human Genome Research at the National Institutes of Health, Bethesda, Maryland.
Nicholas has authored more than 70 scientific publications and has extensive experience in the fields of genomics, molecular biology and cancer research.
Clinical Adoption of Personalized Medicine: Challenges and Solutions
1:10 PM - 2:00 PM